SCHEMBL4409868

SCHEMBL4409868

COc1c(Br)cc(C(C)(C)C)cc1C(=O)Nc1cnc(C)c(C(=O)Nc2ccc(OCc3ccncc3)cc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
MAPT P10636 5/20 0.47
HTT P42858 4/20 0.47
NPSR1 Q6W5P4 3/20 0.47
MAPK14 Q16539 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
LRRK2 Q5S007 2/20 0.40
RAB9A P51151 4/20 0.39
NPC1 O15118 2/20 0.39
PKM P14618 1/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
LMNA P02545 3/20 0.39
KDM4E B2RXH2 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14534466 0.92 MAPK14 (0.45) ALDH1A1SMN1; SMN2MAPTHTTNPSR1
SCHEMBL14534469 0.90 MAPK14 (0.43) ALDH1A1SMN1; SMN2MAPTHTTNPSR1
SCHEMBL4565964 0.88 MAPK14 (0.42) ALDH1A1SMN1; SMN2MAPTHTTNPSR1
SCHEMBL4417851 0.87 MAPK14 (0.44) ALDH1A1SMN1; SMN2MAPTHTTNPSR1
SCHEMBL4413435 0.82 MAPK14 (0.47) ALDH1A1SMN1; SMN2MAPTMAPK14RAB9A
SCHEMBL14534686 0.82 MAPK14 (0.47) ALDH1A1SMN1; SMN2MAPTMAPK14CYP2C9
SCHEMBL4410752 0.81 NPC1 (0.46) ALDH1A1SMN1; SMN2MAPTMAPK14LRRK2
SCHEMBL4417839 0.80 MAPK14 (0.45) ALDH1A1SMN1; SMN2MAPTMAPK14RAB9A
SCHEMBL5489718 0.80 NR3C1 (0.51) SMN1; SMN2MAPK14RAB9ANPC1
SCHEMBL4410224 0.80 MAPK14 (0.43) ALDH1A1SMN1; SMN2MAPTMAPK14LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed
WO-2007056016-A2 BISAMIDE CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-05-18 WO disclosed